Bollard Group LLC Sells 31,232 Shares of Bristol-Myers Squibb (NYSE:BMY)
Bollard Group LLC cut its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 19.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 125,977 shares of the biopharmaceutical company’s stock after selling 31,232 shares during the period. Bollard Group LLC’s holdings in […]